EUVIMEDEUVIMED entdecken
Leserbrief

Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation

Masahiro Iwata iD, Tatsuya Ogawa iD

The Journal of Dermatology · 16.08.2026

DOI: 10.1111/1346-8138.70470 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 16.08.2026. Verfasst von Masahiro Iwata und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Hospital Organization Mito Medical Center, Ibaraki, Japan. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Dermatology, National Hospital Organization Mito Medical Center, Ibaraki, Japan.
  • Department of Dermatology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Allergy Center, University of Tsukuba Hospital, Ibaraki, Japan.

ORCID-Profile: Masahiro Iwata, Tatsuya Ogawa

Zitieren

APA

Iwata, M., & Ogawa, T. (2026). Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70470

Vancouver

Iwata M, Ogawa T. Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70470

BibTeX
@article{Iwata2026,
  author = {Iwata, Masahiro and Ogawa, Tatsuya},
  title = {Pembrolizumab‐Associated Annular Erythematous Lesions With Eccrine‐Predominant Inflammation},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70470}
}
Kostenlos starten →